These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37357076)
1. Clostridium perfringens epsilon prototoxin mutant rpETX Du J; Wang T; Xu L; Wang C; Liu Y; Pan C; Chen X; Zhu Z; Luo Y; Yin C Vaccine; 2023 Jul; 41(32):4762-4770. PubMed ID: 37357076 [TBL] [Abstract][Full Text] [Related]
2. Etx-Y71A as a non-toxic mutant of Clostridium perfringens epsilon toxin induces protective immunity in mice and sheep. Jiang Z; Chang J; Wang F; Qi Y; Li Y; Yu D; Yu L Vaccine; 2020 Sep; 38(42):6553-6561. PubMed ID: 32788135 [TBL] [Abstract][Full Text] [Related]
3. A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia. Li Q; Xin W; Gao S; Kang L; Wang J Hum Vaccin Immunother; 2013 Nov; 9(11):2386-92. PubMed ID: 23835363 [TBL] [Abstract][Full Text] [Related]
4. A non-toxic recombinant bivalent chimeric protein rETX Du J; Liu B; Wang T; Zhu Z; Yin C; Luo Y; Liu Y; Chen X Vaccine; 2023 Feb; 41(6):1232-1238. PubMed ID: 36635138 [TBL] [Abstract][Full Text] [Related]
5. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia. Bokori-Brown M; Hall CA; Vance C; Fernandes da Costa SP; Savva CG; Naylor CE; Cole AR; Basak AK; Moss DS; Titball RW Vaccine; 2014 May; 32(23):2682-7. PubMed ID: 24709588 [TBL] [Abstract][Full Text] [Related]
6. Clostridium perfringens Epsilon Toxin Mutant I51C as a Recombinant Vaccine Candidate Against Enterotoxemia. Nakhaipour E; Kariminik A; Alimolaei M; Bafti MS Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345990 [TBL] [Abstract][Full Text] [Related]
7. Recombinant unpurified rETX Peng X; Li X; Peng G; Feng L; Jiang Y; Luo Y J Vet Med Sci; 2021 Apr; 83(3):441-446. PubMed ID: 33551442 [TBL] [Abstract][Full Text] [Related]
8. Immunization with a novel Clostridium perfringens epsilon toxin mutant rETX(Y196E)-C confers strong protection in mice. Yao W; Kang J; Kang L; Gao S; Yang H; Ji B; Li P; Liu J; Xin W; Wang J Sci Rep; 2016 Apr; 6():24162. PubMed ID: 27048879 [TBL] [Abstract][Full Text] [Related]
9. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies. Bokori-Brown M; Kokkinidou MC; Savva CG; Fernandes da Costa S; Naylor CE; Cole AR; Moss DS; Basak AK; Titball RW Protein Sci; 2013 May; 22(5):650-9. PubMed ID: 23504825 [TBL] [Abstract][Full Text] [Related]
10. Correlation between in vitro cytotoxicity and in vivo lethal activity in mice of epsilon toxin mutants from Clostridium perfringens. Dorca-Arévalo J; Pauillac S; Díaz-Hidalgo L; Martín-Satué M; Popoff MR; Blasi J PLoS One; 2014; 9(7):e102417. PubMed ID: 25013927 [TBL] [Abstract][Full Text] [Related]
11. Comparative neuropathology of ovine enterotoxemia produced by Clostridium perfringens type D wild-type strain CN1020 and its genetically modified derivatives. Garcia JP; Giannitti F; Finnie JW; Manavis J; Beingesser J; Adams V; Rood JI; Uzal FA Vet Pathol; 2015 May; 52(3):465-75. PubMed ID: 24964921 [TBL] [Abstract][Full Text] [Related]
12. New insights into Clostridium perfringens epsilon toxin activation and action on the brain during enterotoxemia. Freedman JC; McClane BA; Uzal FA Anaerobe; 2016 Oct; 41():27-31. PubMed ID: 27321761 [TBL] [Abstract][Full Text] [Related]
13. A non-toxic recombinant protein rSUMO-CPBm4 as a potential vaccine candidate against Clostridium perfringens type C beta enterotoxemia. Goa Y; Du JG; Jirapattharasate C; Galon E; Ji SW; Ran ZG; Xia YQ Trop Biomed; 2023 Dec; 40(4):400-405. PubMed ID: 38308826 [TBL] [Abstract][Full Text] [Related]
14. Enterotoxemia produced by lambda toxin-positive Acevedo HD; Schlesinger MS; Streitenberger N; Henderson E; Asin J; Beingesser J; Uzal FA J Vet Diagn Invest; 2023 Jul; 35(4):448-451. PubMed ID: 37212504 [TBL] [Abstract][Full Text] [Related]
15. Experimental acute Giannitti F; García JP; Adams V; Armendano JI; Beingesser J; Rood JI; Uzal FA Vet Pathol; 2023 Jul; 60(4):412-419. PubMed ID: 37177792 [TBL] [Abstract][Full Text] [Related]
16. Proteolytic processing and activation of Clostridium perfringens epsilon toxin by caprine small intestinal contents. Freedman JC; Li J; Uzal FA; McClane BA mBio; 2014 Oct; 5(5):e01994-14. PubMed ID: 25336460 [TBL] [Abstract][Full Text] [Related]
17. Systematic evaluation of membrane-camouflaged nanoparticles in neutralizing Clostridium perfringens ε-toxin. Xu J; Li D; Kang L; Liu T; Huang J; Li J; Lv J; Wang J; Gao S; Li Y; Yuan B; Zhao B; Wang J; Xin W J Nanobiotechnology; 2023 Mar; 21(1):95. PubMed ID: 36932366 [TBL] [Abstract][Full Text] [Related]
18. Morcrette H; Bokori-Brown M; Ong S; Bennett L; Wren BW; Lewis N; Titball RW NPJ Vaccines; 2019; 4():32. PubMed ID: 31372245 [TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary Lesions in Sheep Produced by Experimental Acute Giannitti F; García JP; Rood JI; Adams V; Armendano JI; Beingesser J; Uzal FA Vet Pathol; 2021 Jan; 58(1):103-113. PubMed ID: 33054683 [TBL] [Abstract][Full Text] [Related]
20. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known. Alves GG; Machado de Ávila RA; Chávez-Olórtegui CD; Lobato FC Anaerobe; 2014 Dec; 30():102-7. PubMed ID: 25234332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]